Stock listing
BOATS:BIOA BioAge Labs, Inc. Stock
US listing (BOATS) of BioAge Labs, Inc. · home listing NASDAQ:BIOA
Follow BioAge Labs, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:BIOA
$5.87 USD -0.07 (-1.2%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:BIOA
- Day range
- $5.63 – $5.93 USDOct 30, 2026
- Volume
- 800,727 sharesOct 30, 2026
- Market cap
- $269.4M USDAt the close on Oct 30, 2026 · price × 45.90M shares outstanding
- 52-week range
- $4.81 – $25.96 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $8.09M USDMedian day 669,600 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BIOA · Home | $5.87 USD | -0.07 (-1.2%) | 800,727 | $5.86 | $5.925 | $5.63 | $5.94 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:BIOA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $5.87 | -0.07 | -1.2% | $5.86 | $5.925 | $5.63 | 800,727 | |
| $5.94 | 0.00 | 0.0% | $5.95 | $6.255 | $5.82 | 845,300 | |
| $5.94 | +0.47 | +8.6% | $5.41 | $5.97 | $5.22 | 1,434,900 | |
| $5.47 | +0.48 | +9.6% | $4.98 | $5.51 | $4.92 | 1,108,000 | |
| $4.99 | -0.11 | -2.2% | $5.10 | $5.15 | $4.92 | 539,000 | |
| $5.10 | -0.43 | -7.8% | $5.48 | $5.48 | $5.05 | 464,200 | |
| $5.53 | +0.02 | +0.4% | $5.45 | $5.62 | $5.411 | 482,300 | |
| $5.51 | -0.05 | -0.9% | $5.61 | $5.70 | $5.43 | 568,500 | |
| $5.56 | +0.57 | +11.4% | $5.00 | $5.64 | $4.97 | 1,204,600 | |
| $4.99 | +0.15 | +3.1% | $4.84 | $5.11 | $4.82 | 1,245,200 | |
| $4.84 | -0.51 | -9.5% | $5.35 | $5.35 | $4.81 | 868,100 | |
| $5.35 | -0.07 | -1.3% | $5.48 | $5.50 | $5.28 | 811,300 | |
| $5.42 | -0.15 | -2.7% | $5.49 | $5.58 | $5.36 | 614,900 | |
| $5.57 | -0.37 | -6.2% | $5.90 | $5.90 | $5.54 | 638,500 | |
| $5.94 | -0.40 | -6.3% | $6.24 | $6.295 | $5.875 | 482,000 | |
| $6.34 | +0.13 | +2.1% | $6.21 | $6.47 | $6.145 | 667,300 | |
| $6.21 | -0.05 | -0.8% | $6.17 | $6.265 | $5.99 | 906,900 | |
| $6.26 | -0.03 | -0.5% | $6.23 | $6.675 | $6.17 | 799,500 | |
| $6.29 | -0.07 | -1.1% | $6.44 | $6.45 | $6.00 | 3,251,700 | |
| $6.36 | -0.25 | -3.8% | $6.65 | $6.65 | $6.25 | 781,200 | |
| $6.61 | -0.20 | -2.9% | $6.92 | $6.92 | $6.47 | 869,600 | |
| $6.81 | -0.28 | -3.9% | $7.06 | $7.17 | $6.70 | 591,100 | |
| $7.09 | -0.05 | -0.7% | $7.20 | $7.26 | $6.97 | 755,200 | |
| $7.14 | -0.04 | -0.6% | $7.19 | $7.27 | $7.07 | 424,900 | |
| $7.18 | +0.13 | +1.8% | $7.11 | $7.425 | $6.96 | 800,100 | |
| $7.05 | -0.16 | -2.2% | $7.26 | $7.295 | $7.03 | 630,300 | |
| $7.21 | -0.68 | -8.6% | $7.79 | $7.88 | $7.19 | 1,010,900 | |
| $7.89 | -0.57 | -6.7% | $8.43 | $8.49 | $7.68 | 618,500 | |
| $8.46 | +0.37 | +4.6% | $8.20 | $8.53 | $8.11 | 1,067,400 | |
| $8.09 | +0.03 | +0.4% | $8.07 | $8.10 | $7.73 | 787,000 | |
| $8.06 | -0.03 | -0.4% | $8.07 | $8.23 | $7.86 | 1,509,000 | |
| $8.09 | +0.34 | +4.4% | $7.85 | $8.36 | $7.70 | 940,100 | |
| $7.75 | -0.43 | -5.3% | $8.21 | $8.275 | $7.62 | 715,800 | |
| $8.18 | -0.30 | -3.5% | $8.48 | $8.50 | $8.02 | 643,500 | |
| $8.48 | -0.01 | -0.1% | $8.52 | $8.635 | $8.39 | 563,400 | |
| $8.49 | -0.16 | -1.8% | $8.71 | $8.89 | $8.28 | 672,100 | |
| $8.65 | -0.52 | -5.7% | $9.07 | $9.07 | $8.60 | 492,700 | |
| $9.17 | -0.225 | -2.4% | $9.38 | $9.40 | $9.02 | 488,300 | |
| $9.395 | -0.195 | -2.0% | $9.60 | $9.645 | $9.324 | 388,000 | |
| $9.59 | +0.09 | +0.9% | $9.39 | $9.76 | $9.39 | 314,500 | |
| $9.50 | -0.23 | -2.4% | $9.90 | $9.98 | $9.415 | 407,300 | |
| $9.73 | +0.21 | +2.2% | $9.59 | $10.05 | $9.425 | 541,300 | |
| $9.52 | +0.02 | +0.2% | $9.28 | $9.72 | $9.15 | 605,000 | |
| $9.50 | -0.15 | -1.6% | $9.61 | $9.63 | $9.20 | 1,032,100 | |
| $9.65 | -0.43 | -4.3% | $10.06 | $10.25 | $9.595 | 452,200 | |
| $10.08 | +0.24 | +2.4% | $9.93 | $10.23 | $9.80 | 475,300 | |
| $9.84 | -0.27 | -2.7% | $10.03 | $10.03 | $9.76 | 503,900 | |
| $10.11 | +0.73 | +7.8% | $9.55 | $10.13 | $9.55 | 498,300 | |
| $9.38 | -0.10 | -1.1% | $9.57 | $9.65 | $9.16 | 658,900 | |
| $9.48 | -0.21 | -2.2% | $9.78 | $9.916 | $9.48 | 453,400 | |
| $9.69 | -1.06 | -9.9% | $10.64 | $10.73 | $9.63 | 776,800 | |
| $10.75 | +0.29 | +2.8% | $10.69 | $10.88 | $10.38 | 412,300 | |
| $10.46 | +0.06 | +0.6% | $10.31 | $10.75 | $10.19 | 478,500 | |
| $10.40 | -0.20 | -1.9% | $10.60 | $10.71 | $10.15 | 671,900 | |
| $10.60 | +0.17 | +1.6% | $10.37 | $10.63 | $10.10 | 444,400 | |
| $10.43 | -0.05 | -0.5% | $10.62 | $10.86 | $10.37 | 536,900 | |
| $10.48 | -0.19 | -1.8% | $10.78 | $10.95 | $10.43 | 614,500 | |
| $10.67 | -0.78 | -6.8% | $11.49 | $11.55 | $10.44 | 761,000 | |
| $11.45 | -0.27 | -2.3% | $11.70 | $11.89 | $11.25 | 594,400 | |
| $11.72 | +0.45 | +4.0% | $11.40 | $11.94 | $11.23 | 953,500 | |
| $11.27 | +0.29 | +2.6% | $10.90 | $11.37 | $10.50 | 844,700 | |
| $10.98 | -0.22 | -2.0% | $11.30 | $11.60 | $10.89 | 1,128,000 | |
| $11.20 | +0.42 | +3.9% | $10.69 | $11.47 | $10.09 | 2,370,100 | |
| $10.78 | +1.74 | +19.2% | $9.50 | $10.96 | $9.18 | 3,533,700 | |
| $9.04 | -15.81 | -63.6% | $8.77 | $10.81 | $8.65 | 9,980,000 | |
| $24.85 | +2.66 | +12.0% | $22.35 | $24.91 | $22.35 | 673,400 |
- Ticker
- BOATS:BIOA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Sep 8, 2026
BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 61 slides
Latest news
BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema
Sep 8, 2026
Closed $9.40 (-2.0%) on Sep 8, 2026
BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates
Aug 5, 2026
Closed $11.27 (+2.6%) on Aug 6, 2026
HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction
Jul 14, 2026
Closed $22.78 (+4.6%) on Jul 14, 2026
BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk
Jun 16, 2026
Closed $20.49 (+3.3%) on Jun 16, 2026
BioAge Labs Reports First Quarter 2026 Financial Results and Provides Business Updates
May 8, 2026
Closed $17.99 (+1.0%) on May 8, 2026
R&D Day Presentation
May 7, 2026
Closed $17.99 (+1.0%) on May 8, 2026
BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026
May 4, 2026
Closed $16.68 (+0.4%) on May 5, 2026
BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP
Apr 21, 2026
Closed $19.61 (+4.3%) on Apr 21, 2026
BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference
Apr 13, 2026
Closed $16.57 (+2.3%) on Apr 14, 2026
BioAge Labs Reports Full Year 2025 Financial Results and Provides Business Updates from the Fourth Quarter of 2025
Mar 24, 2026
Closed $16.11 (-13.5%) on Mar 24, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 61 slides · September 2026
Investor Day (May 2026)
Investor day · 106 slides · May 8, 2026
BioAge Labs, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 40 in all · newest Sep 8, 2026 · oldest 2024
- Decks
- 2 decks · latest September 2026
Where BioAge Labs, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BIOA · Home listing | NASDAQ | United States | USD |
| gettex:Y7G | gettex | Germany | EUR |
| Lang & Schwarz:A40D7P | Lang & Schwarz | Germany | EUR |
| BOATS:BIOA · This page | BOATS | United States | USD |
| Tradegate:Y7G | Tradegate | Germany | EUR |
| LS Exchange:A40D7P | LS Exchange | Germany | EUR |
| Frankfurt:Y7G | Frankfurt | Germany | EUR |
| Dusseldorf:Y7G | Dusseldorf | Germany | EUR |
| Hamburg:Y7G | Hamburg | Germany | EUR |
| Munich:Y7G | Munich | Germany | EUR |
| Stuttgart:Y7G | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about BioAge Labs, Inc.